Post-approval studies (Phase 4)Study completedNCT00181740What this trial is testingConcerta Treatment in Adults With ADHD NOSWho this might be right forADHD NOS Massachusetts General Hospital 30
Not applicableLooking for participantsNCT06978452What this trial is testingBehavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health TrajectoriesWho this might be right forDepression - Major Depressive DisorderBipolarPsychosis+4 more Douglas Mental Health University Institute 560
Post-approval studies (Phase 4)Study completedNCT01238575What this trial is testingGuanfacine for the Treatment of Hyperactivity in Pervasive Developmental DisorderWho this might be right forPervasive Development Disorders Yale University 62
Not applicableUnknownNCT02572180What this trial is testingA Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)Who this might be right forAttention-deficit Hyperactivity Disorder of Childhood or Adolescence Nos University Hospital Tuebingen 90
Post-approval studies (Phase 4)Study completedNCT00844753What this trial is testingAtomoxetine, Placebo and Parent Management Training in AutismWho this might be right forAutismPervasive Development DisorderAsperger's Disorder+1 more University of Rochester 128
Not applicableStudy completedNCT03260725What this trial is testingEvaluating the Feasibility of Internet-delivered PCITWho this might be right forOppositional Defiant DisorderConduct DisorderDisruptive Behavior Disorder Nos Florida International University 40
Large-scale testing (Phase 3)Study completedNCT00266552What this trial is testingThe Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental RetardationWho this might be right forConduct DisorderDisruptive Behavior DisorderOppositional Defiant Disorder Janssen Pharmaceutica N.V., Belgium 118
Post-approval studies (Phase 4)Study completedNCT00586573What this trial is testingOpen-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOSWho this might be right forADHD Massachusetts General Hospital 34
Large-scale testing (Phase 3)Study completedNCT00250354What this trial is testingThe Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental RetardationWho this might be right forConduct DisorderOppositional Defiant DisorderDisruptive Behavior Disorder Janssen Pharmaceutica N.V., Belgium 110
Not applicableStudy completedNCT00181857What this trial is testingRisk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)Who this might be right forADHD Massachusetts General Hospital 58
Post-approval studies (Phase 4)Study completedNCT00181766What this trial is testingStrattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)Who this might be right forADHD NOS Massachusetts General Hospital 45
Not applicableStudy completedNCT00916071What this trial is testingAssociation Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating DisordersWho this might be right forBulimia NervosaEating DisordersADHD Massachusetts General Hospital 64
Not applicableNot Yet RecruitingNCT07661823What this trial is testingQAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)Who this might be right forAsperger's DisorderAsperger DisorderAutism Disorder+41 more Veterans Recovery Network Inc. 1,000,000